Search

Displaying results 6041 - 6050 of 10000 in total
  1. Drug

    Platinum

    go.drugbank.com/drugs/DB12257
    Investigational

    Platinum is under investigation for the treatment of Metastatic Breast Cancer, Non-small Cell Lung Cancer, Gastric Large Cell Neuroendocrine Carcinoma, Colorectal Large Cell Neuroendocrine Carcinoma, and Pancreatic Large Cell Neuroendocr...

    Categories: Compounds used in a research, industrial, or household setting
  2. Drug

    Losmapimod

    go.drugbank.com/drugs/DB12270
    Investigational

    Losmapimod has been investigated for the prevention of Chronic Obstructive Pulmonary Disease.

    Categories: Heterocyclic Compounds, 1-Ring
  3. Drug

    ORE-1001

    go.drugbank.com/drugs/DB12271
    Investigational

    ORE1001 has been used in trials studying the treatment of Mild to Moderate Ulcerative Colitis. It is an ACE2 inhibitor.

    Categories: Heterocyclic Compounds, 1-Ring
  4. Drug

    Seviteronel

    go.drugbank.com/drugs/DB12275
    Investigational

    Seviteronel has been used in trials studying the treatment of CRPC, Prostate Cancer, and Castration-resistant Prostate Cancer.

    Categories: Heterocyclic Compounds, 1-Ring, Cytochrome P-450 Enzyme Inhibitors
  5. Drug

    Luspatercept

    go.drugbank.com/drugs/DB12281
    ApprovedInvestigational

    Luspatercept is a recombinant fusion protein comprised of a modified extracellular domain of activin receptor type IIB fused to the FC domain of human IgG1. … [A187829,L42455] It was first approved for use in the United States in November 2019 under the brand name Reblozyl® for the treatment of anemia in patients with beta thalassemia who require regular blood

    Products: REBLOZYL®
  6. Drug

    LY-2608204

    go.drugbank.com/drugs/DB12284
    Investigational

    LY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.

    Categories: Heterocyclic Compounds, 1-Ring
  7. Drug

    Verubecestat

    go.drugbank.com/drugs/DB12285
    Investigational

    Verubecestat is Merck’s investigational oral β-site amyloid precursor protein cleaving enzyme (BACE1 or β secretase) inhibitor. … In the study, administration of Verubecestat at doses of 12, 40 and 60 mg resulted in a dose-dependent and sustained reduction in the levels of Ab40, a measure of BACE1 activity, in CSF from baseline of

    Categories: Heterocyclic Compounds, 1-Ring
  8. Drug

    Simendan

    go.drugbank.com/drugs/DB12286
    Experimental

    Categories: Heterocyclic Compounds, 1-Ring, Phosphodiesterase 3 Inhibitors
  9. Drug

    Piromelatine

    go.drugbank.com/drugs/DB12288
    Investigational

    Piromelatine has been used in trials studying the treatment of Alzheimer's Disease.

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  10. Drug

    Puerarin

    go.drugbank.com/drugs/DB12290
    Investigational

    Puerarin has been investigated for the treatment of Alcohol Abuse.

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring